Výsledky vyhledávání - "Veronica R. Placencio"

Akademický článek

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia

Autor: Gillian Gresham, Veronica R. Placencio‐Hickok, Marie Lauzon, Tyra Nguyen, Haesoo Kim, Sejal Mehta, Shirley Paski, Stephen J. Pandol, Arsen Osipov, Jun Gong, Laith H. Jamil, Nicholas Nissen, Simon K. Lo, Andrew E. Hendifar

Publikováno v: Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 6, Pp 1959-1968 (2021)

Abstract Background Advanced pancreatic ductal adenocarcinoma (PDAC) is characterized by progressive weight loss and nutritional deterioration. This wasting has been linked to poor survival outcomes, alterations in host defenses, decreased functional

Externí odkaz: https://doaj.org/article/c41de02b68744dcc8025ab26ceb94b9b

Zobrazit plný text záznamu

Akademický článek

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms

Autor: Michelle Guan, BS, Ingrid He, MD, Michael Luu, MPH, John David, MD, Jun Gong, MD, Veronica R. Placencio-Hickok, PhD, Robert S. Reznik, MD, Richard Tuli, MD, PhD, Andrew E. Hendifar, MD

Publikováno v: Advances in Radiation Oncology, Vol 4, Iss 3, Pp 513-519 (2019)

Purpose: Bone metastases are reported in 10% to 12% of patients with neuroendocrine neoplasms (NENs) and can lead to pain and skeletal-related events (SREs), resulting in diminished quality of life and functional status. In other solid tumors with bo

Externí odkaz: https://doaj.org/article/2716be1c95554495b34cd8dc44d1f780

Zobrazit plný text záznamu

Akademický článek

Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers

Autor: John M. David, MD, Sungjin Kim, MS, Veronica R. Placencio-Hickok, PhD, Arman Torosian, BS, Andrew Hendifar, MD, Richard Tuli, MD, PhD

Publikováno v: Advances in Radiation Oncology, Vol 4, Iss 2, Pp 302-313 (2019)

Purpose: Locally advanced pancreatic cancer (LAPC) treatment has varying practice patterns with poor outcomes. We investigated treatment using single-agent chemotherapy and multiagent chemotherapy (MAC) with or without radiation therapy (RT) at high-

Externí odkaz: https://doaj.org/article/722c83ef6583400cab20bfe3d42179e9

Zobrazit plný text záznamu

Exceptional Response to Erdafitinib in FGFR2-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Autor: Camille F, Ng, John, Glaspy, Veronica R, Placencio-Hickok, Shant, Thomassian, Jun, Gong, Arsen, Osipov, Andrew E, Hendifar, Natalie, Moshayedi

Publikováno v: Journal of the National Comprehensive Cancer Network. 20:1076-1079

Despite advances in cancer therapeutics, pancreatic ductal adenocarcinoma (PDAC) remains among the deadliest malignancies, with a poor prognosis at time of diagnosis. Research in PDAC has suggested that adaptive signaling in the tumor microenvironmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8dd119b95cd9ff5b6afef80b4e7796b
https://doi.org/10.6004/jnccn.2022.7039

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání